Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01471483 · ClinicalTrials.gov registry record

Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
50
Enrollment target

NCT01471483: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01471483 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01471483 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

Older woman with ovarian cancer have a worse prognosis compared to younger patients. However, the reason is not known. Currently, the standard of care is to evaluate younger and older patients with cancer the same way. However, older patients with cancer often have more complicated issues to manage. For example, older patients often have other medical problems, take more medications, and be dependent on others for help and transportation. Too often, the medical team is unaware of these issues which can effect the patients care. The purpose of this study is to apply a set of questions designed specifically for patients with cancer who are older than 65 years of age. These questions are called a geriatric assessment. The investigators want to better understand which older patients with ovarian cancer will be able to tolerate the chemotherapy and surgery and why. This study will also see if a telephone call from a nurse who specializes in caring for older patients will improve patient care. This study will determine how feasible it is to perform geriatric assessments and telephone calls in patients with ovarian cancer.

Interventions

  • BEHAVIORAL geriatric assessment and telephone call from nurse
  • OTHER geriatric assessment and no call from nurse

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2011-11-08
Est. Completion 2025-04-17

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT01471483

The ClinicalTrials.gov registry entry for NCT01471483 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which geriatric assessment and telephone call from nurse is the first listed.

NCT01471483 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01471483 about?

NCT01471483 is a clinical study titled "Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer". Older woman with ovarian cancer have a worse prognosis compared to younger patients. However, the reason is not known. Currently, the standard of care is to evaluate younger and older patients with cancer the same way. However, older patients with cancer often have more complicated issues to manage....

What is the current status of trial NCT01471483?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2011-11-08. Estimated completion is 2025-04-17.

What interventions are being tested in trial NCT01471483?

The interventions under investigation include: geriatric assessment and telephone call from nurse (BEHAVIORAL), geriatric assessment and no call from nurse (OTHER).

Who is sponsoring clinical trial NCT01471483?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.